These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21748292)

  • 1. Predictive value of BI-RADS classification for breast imaging in women under age 50.
    Kennedy G; Markert M; Alexander JR; Avisar E
    Breast Cancer Res Treat; 2011 Dec; 130(3):819-23. PubMed ID: 21748292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.
    Thomassin-Naggara I; Trop I; Chopier J; David J; Lalonde L; Darai E; Rouzier R; Uzan S
    Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performance of users in tropical areas with the BI-RADS classification of breast lesions for predicting malignancy].
    Gonsu Kamga JE; Moifo B; Sando Z; Guegang Goudjou E; Nko'o Amvene S; Gonsu Fotsin J
    Med Sante Trop; 2013; 23(4):439-44. PubMed ID: 24334372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-negative rate of combined mammography and ultrasound for women with palpable breast masses.
    Chan CH; Coopey SB; Freer PE; Hughes KS
    Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.
    Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
    Wiratkapun C; Lertsithichai P; Wibulpholprasert B
    J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive predictive value of BI-RADS categorization in an Asian population.
    Tan YY; Wee SB; Tan MP; Chong BK
    Asian J Surg; 2004 Jul; 27(3):186-91. PubMed ID: 15564158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BI-RADS for sonography: positive and negative predictive values of sonographic features.
    Hong AS; Rosen EL; Soo MS; Baker JA
    AJR Am J Roentgenol; 2005 Apr; 184(4):1260-5. PubMed ID: 15788607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging.
    Satake H; Nishio A; Ikeda M; Ishigaki S; Shimamoto K; Hirano M; Naganawa S
    AJR Am J Roentgenol; 2011 Jan; 196(1):202-9. PubMed ID: 21178068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
    Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
    Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Breast Ultrasound in Breast Cancer Screening of Women With Dense Breasts: Reader Study of Mammography-Negative and Mammography-Positive Cancers.
    Giger ML; Inciardi MF; Edwards A; Papaioannou J; Drukker K; Jiang Y; Brem R; Brown JB
    AJR Am J Roentgenol; 2016 Jun; 206(6):1341-50. PubMed ID: 27043979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography.
    Kim EK; Ko KH; Oh KK; Kwak JY; You JK; Kim MJ; Park BW
    AJR Am J Roentgenol; 2008 May; 190(5):1209-15. PubMed ID: 18430833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
    Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
    Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gail model predicts breast cancer in women with suspicious radiographic lesions.
    Weik JL; Lum SS; Esquivel PA; Tully RJ; Bae WC; Petersen FF; Jaque JM; Reeves ME; Garberoglio CA
    Am J Surg; 2005 Oct; 190(4):526-9. PubMed ID: 16164914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.